Actos | Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Tabulated list of adverse reactions: Adverse reactions reported in excess (>0.5%) of placebo and as more than an isolated case in patients receiving pioglitazone in double-blind studies are listed as follows as MedDRA preferred term by system organ class and absolute frequency. Frequencies are defined as: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to < 1/1,000); very rare (< 1/10,000); not known (cannot be estimated from the available data). Within each system organ class, adverse reactions are presented in order of decreasing incidence followed by decreasing seriousness. (See Table 6.)

Click on icon to see table/diagram/image

View ADR Reporting Link

Actos Adverse Reactions

pioglitazone

Manufacturer:

Bora Pharma

Distributor:

DKSH